Halper Sadeh LLC Encourages CFLT, EB, RPTX Shareholders to Contact the Firm to Discuss Their Rights

(NASDAQ:CFLT),(NYSE:EB),(NASDAQ:RPTX), NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Confluent, Inc. (NASDAQ: CFLT)'s sale to IBM for $31.00 per share. If you are a Confluent […]

‘Twas the Night Before Travel: Tips for a Merry Journey

'Twas the night before travel, the suitcases were spreadTravellers rushed, checking lists in their head.But with planning and cheer, your trip can be brightFollow these tips and your journey takes flight: Give Yourself the Gift of TimeArrive early, dear traveller, don't dash through the snow,Two hours for domestic, three for abroad you should show.Traffic and

ALT5 Investor Alert: Hagens Berman Investigates ALT5 Sigma (ALTS) Over Auditor Resignation and Potentially False Financials

(NASDAQ:ALTS), SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) — National shareholder rights law firm Hagens Berman has opened an investigation into ALT5 Sigma Corporation (NASDAQ: ALTS) following a cascade of regulatory and management failures that led to the company's stock cratering nearly 80%. The investigation focuses on whether ALT5 misled investors about the stability and

ALT5 Investor Alert: Hagens Berman Investigates ALT5 Sigma (ALTS) Over Auditor Resignation and Potentially False Financials

ALT5 Investor Alert: Hagens Berman Investigates ALT5 Sigma (ALTS) Over Auditor Resignation and Potentially False Financials Partner Reed Kathrein Scrutinizes Allegations of Illicit Enrichment and Collapse of Financial Reporting Controls Following $1.5 Billion Offering GlobeNewswire December 08, 2025 SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) — National shareholder rights law firm Hagens Berman has opened

Co-Diagnostics JV, CoSara, to Participate at VIROCON 2025 in Pune, India

Ongoing Phase II preclinical study data for Co-Dx PCR MTB and HPV tests support advancement to clinical performance testing Co-Diagnostics, Inc.(Nasdaq: CODX)(“Co-Dx” or “the Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that CoSara Diagnostics Pvt. Ltd. (“CoSara”), the joint venture (“JV”) between Ambalal

Ardent Health (ARDT) Investor Alert: Hagens Berman Investigating Accounting Estimate Change and $97M Reserve Issue Driving 33% Plunge

(NYSE:ARDT),(NYSE:ARDT), SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) — Prominent shareholder rights law firm Hagens Berman has opened an investigation into potential securities law violations by Ardent Health, Inc. (NYSE: ARDT) following the company's recent Q3 2025 financial disclosures. The disclosures revealed significant adverse accounting adjustments totaling $97 million that sent the stock tumbling over

Ardent Health (ARDT) Investor Alert: Hagens Berman Investigating Accounting Estimate Change and $97M Reserve Issue Driving 33% Plunge

Ardent Health (ARDT) Investor Alert: Hagens Berman Investigating Accounting Estimate Change and $97M Reserve Issue Driving 33% Plunge Lead Partner Reed Kathrein: Scrutiny Focuses on Extent of Leadership Awareness Regarding Chronic Payor Denials and Collectability Issues GlobeNewswire December 08, 2025 SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) — Prominent shareholder rights law firm Hagens Berman

OWL Investors Encouraged to Seek Lead Plaintiff Role in Blue Owl Capital Inc. Securities Fraud Case with Johnson Fistel

(NYSE:OWL), SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) — Johnson Fistel, PLLP announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Blue Owl Capital Inc. (NYSE: OWL) securities between February 6, 2025 and November 16, 2025, inclusive (the “Class Period”). The lawsuit seeks to recover losses

OWL Investors Encouraged to Seek Lead Plaintiff Role in Blue Owl Capital Inc. Securities Fraud Case with Johnson Fistel

OWL Investors Encouraged to Seek Lead Plaintiff Role in Blue Owl Capital Inc. Securities Fraud Case with Johnson Fistel GlobeNewswire December 08, 2025 SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) — Johnson Fistel, PLLP announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Blue Owl Capital

Scroll to Top